← Eichor
Study identifier: NCT07058207 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Weight Management in Obese Cancer Patients During Curative Active Treatment

Condition: Obesity · Solid Neoplasm · Stage II-IV  ·  Sponsor: Institut d'Investigació Biomèdica de Bellvitge

PhaseNA
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a feasibility study intervention to fifty cancer patients with obesity and with newly diagnosed stage II-IV solid tumors undergoing curative treatment recruited at the Catalan Institute of Oncology (ICO) in L'Hospitalet, Spain. The investigators hypothesize that weight management during cancer treatment could enhance health outcomes for this population. The feasibility of a multimodal weight loss management program will be assesses, including a personalized hypocaloric and high-protein diet combined with a supervised exercise home-program and behavioural support.

This description comes directly from the study's public registry record.

Talk to the study team

Lorena Arribas  ·  +34932607751  ·  larribas@iconcologia.net

Marta Puig  ·  +34932607751  ·  mpuig@iconcologia.net

Always discuss trial participation with your own doctor first.

Locations (1)

Institut Català d'Oncologia. Catalan Institute of OncologyL'Hospitalet de Llobregat, Barcelona, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07058207